Wix.Com Ltd (WIX) Stock Price Today
Aura AI Summary
Key Stats
- $2.21BMarket Cap
- -Volume
- TechnologySector
- $184.2452W High
- $40.4352W Low
- -Typical Hold Time
- $1.77BEnterprise Value
- -Div Yield
- -Trading Activity
Track Wix.Com Ltd (WIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Wix.Com Ltd has traded between a low of $40.43 and a high of $184.24, highlighting its annual price range. Buy and sell Wix.Com Ltd shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Most Recent News
Halper Sadeh LLC probes fairness of deals for ESI, CRNX, SOLS shareholders amid merger sales.
Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm hi...
Comcast faces price target cuts amid rising competition and NBCUniversal spin-off plans
Investment banks Scotiabank and Bernstein have lowered their price targets for Comcast due to increased competition from new players like SpaceX's Starlink and valuation risks. Comcast is also undergoing a major strategic shift by spinning off its NB...
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth
The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.